{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:04:59Z","timestamp":1760551499113,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejps.2021.105936","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T04:47:14Z","timestamp":1626238034000},"page":"105936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["MATERNAL AND FETAL BUPRENORPHINE PHARMACOKINETICS IN PREGNANT SHEEP DURING TRANSDERMAL PATCH DOSING"],"prefix":"10.1016","volume":"165","author":[{"given":"Henriikka","family":"Hakom\u00e4ki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Kokki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"R\u00e4s\u00e4nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna-Marja","family":"Voipio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veli-Pekka","family":"Ranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merja","family":"Kokki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejps.2021.105936_bib0001","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2885.2009.01058.x","article-title":"Plasma buprenorphine concentrations after the application of a 70 \u03bcg\/h transdermal patch in dogs. Preliminary report","volume":"32","author":"Andaluz","year":"2009","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.ejps.2021.105936_bib0002","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.ejps.2021.105936_bib0003","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1742-7843.2010.00649.x","article-title":"Pharmacokinetic\/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models","volume":"108","author":"Andresen","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.ejps.2021.105936_bib0004","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1479-828X.2012.01424.x","article-title":"Buprenorphine exposure in infants of opioid-dependent mothers at birth","volume":"52","author":"Bartu","year":"2012","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.ejps.2021.105936_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.09.095","article-title":"Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy","volume":"216","author":"Bastian","year":"2017","journal-title":"Am. J. Obstetrics Gynecol."},{"issue":"5","key":"10.1016\/j.ejps.2021.105936_bib0006","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ultrasmedbio.2017.01.010","article-title":"Effect of hypoxemia on fetal ventricular deformation in a chronically instrumented sheep model","volume":"43","author":"Bhide","year":"2017","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.ejps.2021.105936_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.06.029","article-title":"An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy","volume":"217","author":"Caritis","year":"2017","journal-title":"Am. J. Obstetrics Gynecol."},{"issue":"1","key":"10.1016\/j.ejps.2021.105936_bib0009","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1360-0443.2012.04039.x","article-title":"Differences in the profile of neonatal abstinence syndrome signs in methadone-versus buprenorphine-exposed neonates","volume":"107","author":"Gaalema","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.ejps.2021.105936_bib0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2125.2010.03759.x","article-title":"(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy","volume":"70","author":"Gordon","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105936_bib0008","unstructured":"Government of Finland, 2013. Decree on the Protection of Animals Used for Scientific or Educational Purposes (564\/2013). https:\/\/finlex.fi\/en\/laki\/kaannokset\/2013\/en20130564.pdf Published 2013. Accessed October 1, 2020."},{"issue":"31","key":"10.1016\/j.ejps.2021.105936_bib0011","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid Use Disorder Documented at Delivery Hospitalization \u2014 United States, 1999\u20132014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR. Morbidity Mortality Weekly Report"},{"issue":"2","key":"10.1016\/j.ejps.2021.105936_bib0012","doi-asserted-by":"crossref","first-page":"e00726","DOI":"10.1002\/prp2.726","article-title":"Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection","volume":"9","author":"Hakom\u00e4ki","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"issue":"2","key":"10.1016\/j.ejps.2021.105936_bib0013","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.ejps.2021.105936_bib0014","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2012.11.014","article-title":"Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans","volume":"131","author":"Huestis","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.ejps.2021.105936_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.01.040","article-title":"Maternal buprenorphine treatment and fetal neurobehavioral development","volume":"216","author":"Jansson","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ejps.2021.105936_bib0016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review HHS public access","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.ejps.2021.105936_bib0017","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2165\/11632820-000000000-00000","article-title":"Methadone and buprenorphine for the management of opioid dependence in pregnancy","volume":"72","author":"Jones","year":"2012","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ejps.2021.105936_bib0018","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpainsymman.2012.06.014","article-title":"Once-weekly transdermal buprenorphine application results in sustained and consistent steady-state plasma levels","volume":"46","author":"Kapil","year":"2013","journal-title":"J. Pain Symptom Manage."},{"issue":"10","key":"10.1016\/j.ejps.2021.105936_bib0019","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/aogs.13378","article-title":"Oxycodone pharmacokinetics and fetal exposure after intravenous or epidural administration to the ewe","volume":"97","author":"Kinnunen","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"5","key":"10.1016\/j.ejps.2021.105936_bib0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","article-title":"Pharmacokinetic changes during pregnancy and their clinical relevance","volume":"33","author":"Loebstein","year":"1997","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.ejps.2021.105936_bib0021","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"issue":"17","key":"10.1016\/j.ejps.2021.105936_bib0022","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/vr.160.17.578","article-title":"Use of a transdermal matrix patch of buprenorphine in cats: Preliminary pharmacokinetic and pharmacodynamic data","volume":"160","author":"Murrell","year":"2007","journal-title":"Vet. Rec."},{"key":"10.1016\/j.ejps.2021.105936_bib0023","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajp.2019.07.030","article-title":"\u2018Too little dose \u2013 too early discontinuation?\u2019\u2014Effect of buprenorphine dose on short term treatment adherence in opioid dependence","volume":"44","author":"Muruganandam","year":"2019","journal-title":"Asian J. Psychiatry"},{"issue":"1","key":"10.1016\/j.ejps.2021.105936_bib0024","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/jpet.300.1.26","article-title":"Transplacental transfer and metabolism of buprenorphine","volume":"300","author":"Nanovskaya","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2021.105936_bib0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00008877-200211000-00005","article-title":"Delta opioid antagonist effects of buprenorphine in rhesus monkeys","volume":"13","author":"Negus","year":"2002","journal-title":"Behav. Pharmacol."},{"journal-title":"Act on the Protection of Animals Used for Scientific or Educational Purposes. 497\/","year":"2013","author":"Parliament of Finland","key":"10.1016\/j.ejps.2021.105936_bib0026"},{"issue":"3","key":"10.1016\/j.ejps.2021.105936_bib0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tvjl.2010.01.013","article-title":"Antinociceptive efficacy and plasma concentrations of transdermal buprenorphine in dogs","volume":"187","author":"Pieper","year":"2011","journal-title":"Vet. J."},{"key":"10.1016\/j.ejps.2021.105936_bib0028","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"year":"2010","series-title":"EUR-Lex: 2010\/63\/EU","author":"The European Parliament and the Council of the European Union","key":"10.1016\/j.ejps.2021.105936_bib0029"},{"issue":"6","key":"10.1016\/j.ejps.2021.105936_bib0030","article-title":"Pharmacokinetics of sustained-release and transdermal buprenorphine in g\u00f6ttingen minipigs (Sus scrofa domestica)","volume":"53","author":"Thiede","year":"2014","journal-title":"J. Am. Ass. Laboratory Animal Sci."},{"issue":"2","key":"10.1016\/j.ejps.2021.105936_bib0031","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1176\/appi.ps.201300256","article-title":"Medication-assisted treatment with buprenorphine: assessing the evidence","volume":"65","author":"Thomas","year":"2014","journal-title":"Psychiatr. Serv."},{"issue":"3","key":"10.1016\/j.ejps.2021.105936_bib0032","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.vascn.2008.08.001","article-title":"Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling","volume":"58","author":"Upton","year":"2008","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejps.2021.105936_bib0033","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jcph.718","article-title":"Dose-dependent flux of buprenorphine following transdermal administration in healthy subjects","author":"Wang","year":"2016","journal-title":"J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejps.2021.105936_bib0034","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/bcp.13642","article-title":"Gestational changes in buprenorphine exposure: a physiologically-based pharmacokinetic analysis","volume":"84","author":"Zhang","year":"2018","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721002396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721002396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:59:30Z","timestamp":1760529570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721002396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":34,"alternative-id":["S0928098721002396"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105936","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MATERNAL AND FETAL BUPRENORPHINE PHARMACOKINETICS IN PREGNANT SHEEP DURING TRANSDERMAL PATCH DOSING","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105936"}}